­
4:44 pm 4:44 pm

Pneumonia Vaccine Shown to Actually Increase Bacterial Infections It Is Supposed to Prevent

December 28th, 2014|Authorities Speak Out, blog, Pneumococcal, Pneumococcal Vaccine Ineffectiveness, Pneumococcal Vaccine Risk, Vaccine Ineffectiveness, Vaccine Risks|

It’s estimated that nearly one in 7 U.S. adults have been diagnosed with sinusitis in the past 12 months, which occurs when the mucous membranes in your nose and sinuses become irritated. In most of these cases (90-98%) a virus is the cause, whereas in 2-10% of cases, a bacterial infection is also present.These bacterial infections are becoming increasingly drug-resistant and therefore harder and harder to treat, which is why the Infectious Diseases Society of America (IDSA) recently issued new treatment guidelines for sinusitis.

Alarmingly, however, buried on page 16 of their report is the acknowledgement that certain hard-to-treat bacterial infections in children are on the rise because of the widespread use of the conjugated pneumococcal vaccines!

Bacterial Infections on the Rise Since Introduction of the Pneumonia Vaccine

The IDSA report states:
” … both the prevalence of H. influenzae (40%– 45%) and proportion of b-lactamase–producing H. influenzae (37%–50%) (extrapolated from middle ear fluid cultures of children with acute otitis media) have markedly increased among other upper respiratory tract infections since the widespread use of conjugated pneumococcal vaccines… Whereas S. pneumoniae was more common than H. influenzae prior to 2000, the prevalence of H. influenzae has clearly increased while that of S. pneumoniae has decreased in the post–pneumococcal vaccine era, such that currently they are approximately equal … “

In the United States the Prevnar vaccine, which is used to prevent pneumoccocal disease that can cause meningitis and bloodstream infections in young children, was licensed in 2000 and has been given to infants in four

9:35 pm 9:35 pm

Vaccine Cases Fill This Court s Docket

October 15th, 2014|Authorities Speak Out, blog, Vaccine Ineffectiveness|

From: National Law Journal - Jenna Greene, The National Law Journal

In fiscal year 2014, the special court in Washington, D.C., ordered $202M be paid to 365
victims.

October 13, 2014

Until he was 4 months old, Braden Lerwick was a normal, healthy baby. But in the days and
weeks after he got a routine vaccination, he began crying inconsolably, grew unresponsive and
suffered seizures. Now age 10, he is profoundly handicapped, unable to speak or feed himself.
The likely cause: the diphtheria-tetanus-acellular pertussis, or DTaP, vaccine.
This is not a horror story from an antivaccination group. It is a finding of fact by a special master
at an obscure federal court that decides when vaccines have injured or killed people and
awards them compensation. In Braden’s case, it will be millions of dollars for a lifetime of
constant care.
As the antivaccination movement grows—and with it, outbreaks of diseases such as whooping
cough, mumps and measles—the eight special masters at the so-called vaccine court within the
U.S. Court of Federal Claims are under increasing pressure. What was intended to be a quick
and easy program for awarding compensation when it was created 28 years ago has become
markedly adversarial, with dueling medical experts offering complex theories about injuries
caused by vaccines.
To some, the court is a failure, an experiment in no-fault tort reform gone awry. “I’m so
disappointed in it,” said Michael Hugo, senior litigation counsel to Khorrami Boucher’s Boston
office. In 1986, he lobbied alongside pharmaceutical companies to pass the National Childhood
Vaccine Injury Act, which created the vaccine compensation program. Now, he said, “it makes
me sick to

1:38 pm 1:38 pm

What Whistleblowers Tell Us About Vaccine Safety and Effectiveness

October 9th, 2014|blog, Vaccine Ineffectiveness|

By Dr. Mercola

In 2010, two Merck virologists filed a federal lawsuit under the False Claims Act against their former employer, alleging the vaccine maker lied about the effectiveness of their mumps vaccine (which is part of the trivalent measles, mumps, and rubella (MMR) vaccine).

The whistleblowers, Stephen Krahling and Joan Wlochowski, claimed they witnessed “firsthand the improper testing and data falsification in which Merck engaged to artificially inflate the vaccine’s efficacy findings.”

They charged that Merck used improper testing techniques; manipulated testing methodology; abandoned undesirable test results; falsified test data; and failed to adequately investigate and report the diminished efficacy of its mumps vaccine.

They also claim Merck falsely verified that each manufacturing lot of mumps vaccine would be as effective as identified in the labeling; falsely certified the accuracy of applications filed with the FDA; falsely certified compliance with the terms of the CDC purchase contract; and mislabeled, misbranded and falsely certified its mumps vaccine, among other violations.

Merck allegedly falsified the data to hide the fact that the mumps vaccine in the MMR shot has significantly declined in effectiveness.

By artificially inflating the mumps vaccine efficacy, Merck was able to continue selling MMR vaccine in the US and maintain its monopoly over the mumps vaccine market in the US and other nations that purchase Merck’s MMR vaccine.

This is the main point of contention of a second class-action lawsuit, filed by Chatom Primary Care in 2012.

US District Court Judge C. Darnell Jones has now given both of these lawsuits the green light to proceed.

Also

3:39 pm 3:39 pm

CDC Confirms 1st U.S. Ebola Case: “We Will Stop It Here”

October 1st, 2014|blog, Ebola Vaccine Ineffectiveness, Ebola Vaccine Risk|

A person who arrived in Dallas from Liberia a week ago tested positive for Ebola Tuesday, becoming the first person diagnosed in the U.S. with the potentially deadly virus, the City of Dallas confirmed.

There is no doubt in my mind that we will stop it here.Dr. Thomas Frieden, director of the Centers for Disease Control and Prevention

The patient was hospitalized and placed in isolation at Texas Health Presbyterian Hospital Sunday after symptoms appeared four days earlier, on Sept. 24. Hospital officials listed him in serious condition Wednesday.

Because the patient showed no symptoms of the virus when he arrived in the U.S. Sept. 20, there was no risk to fellow airline passengers, according to CDC Director Dr. Thomas Frieden.

“We’ve stopped every Ebola outbreak that’s ever occurred in Africa expect for this one,” he said. And this one could have been stopped  if we had gotten in there earlier.

The CDC will ensure that the patient will be treated in a way that minimizes the risk of spreading infection, Frieden said. He also said a team is in Dallas to identify anyone the patient might have infected and monitor them for 21 days.

“We will stop Ebola in its tracks in the U.S.,” he said.

Dallas County Health Director Zachary Thompson told

2:03 pm 2:03 pm

Outbreak of Measles Among Persons With Prior Evidence of Immunity, New York City, 2011

September 24th, 2014|Authorities Speak Out, Measles Vaccine Ineffectiveness, Vaccine Ineffectiveness|

Abstract

Background. Measles was eliminated in the United States through high vaccination coverage and a public health system able to rapidly respond to measles. Measles may occur among vaccinated individuals, but secondary transmission from such individuals has not been documented.

Methods. Suspected patients and contacts exposed during a measles outbreak in New York City in 2011 were investigated. Medical histories and immunization records were obtained. Cases were confirmed by detection of measles-specific immunoglobulin M and/or RNA. Tests for measles immunoglobulin G (IgG), IgG avidity, measurement of measles neutralizing antibody titers, and genotyping were performed to characterize the cases.

Results. The index patient had 2 doses of measles-containing vaccine; of 88 contacts, 4 secondary patients were confirmed who had either 2 doses of measles-containing vaccine or a past positive measles IgG antibody. All patients had laboratory confirmation of measles infection, clinical symptoms consistent with measles, and high-avidity IgG antibody characteristic of a secondary immune response. Neutralizing antibody titers of secondary patients reached >80 000 mIU/mL 3–4 days after rash onset and that of the index was <500 mIU/mL 9 days after rash onset. No additional cases of measles occurred among 231 contacts of secondary patients. Conclusions. This is the first report of measles transmission from a twice-vaccinated individual with documented secondary vaccine failure. The clinical presentation and laboratory data of the index patient were typical of measles in a naive individual. Secondary patients had robust anamnestic antibody responses. No tertiary cases occurred despite numerous contacts. This outbreak underscores the need for thorough epidemiologic and laboratory investigation of suspected cases

10:18 pm 10:18 pm

National Vaccine Information Center Calls for Removal of Vaccine Safety Oversight from Department of Health and Human Services

September 2nd, 2014|Authorities Speak Out, blog, Vaccine Ineffectiveness, Vaccine Risks|

By Barbara Loe Fisher

On Aug. 27, 2014 a senior scientist at the Centers for Disease Control and Prevention (CDC)1 publicly admitted2 that he and other CDC officials, including the current CDC’s Director of Immunization Safety,3, 4 published a study about MMR vaccine safety in 20045 that “omitted statistically significant information” and “did not follow the final study protocol. “He said the study “omitted relevant findings in a particular study for a particular sub group for a particular vaccine” and added that “there have always been recognized risks for vaccination” and “it is the responsibility for the CDC to properly convey risks.”

CDC: A History of Limiting Transparency

We couldn’t agree more. CDC officials should not be in the business of deliberately withholding information from the public about vaccine risks that may be greater for some children than other children.6 Unfortunately, CDC officials have a long history of limiting transparency7, 8 and being less than honest with the American people about what it does and does not know about vaccine risks.9, 10

Last July, a RAND Corporation study commissioned and funded by DHHS was published proclaiming that vaccines “are very safe.”11 What was not made clear to the public was that the study was designed and peer reviewed by high-level CDC officials, including the CDC’s Director of Immunization Safety.12

This is a big problem for parents being ordered to give their children every government recommended vaccine – no exceptions and no questions asked.13, 14

NVIC Calls on Congress to Take Action

2:00 pm 2:00 pm

Fraud at the CDC uncovered, 340% increased risk of autism hidden from public

August 26th, 2014|Autism (ASD), blog, MMR Vaccine Ineffectiveness, MMR Vaccine Risk|

CNN PRODUCER NOTE

CNN iReport is the network’s user-generated news community. This story was initially pulled for further review after it was flagged by the community. CNN has reached out to the CDC for comment and is working to confirm the claims in this iReport.

By eplettner | Posted August 24, 2014 | Seminole, Florida

A top researcher at the Centers for Disease Control and Prevention (CDC) played a key role in helping uncover data manipulation by the CDC. This fraud obscured a higher incidence of autism in African-American boys. The whistleblower, Dr. William Thompson, came forward after a Freedom of Information Act (FOIA) request for original data on an autism study was filed and these highly sensitive documents were received with the assistance of U.S. Representative Darrell Issa, Chairman of the House Oversight and Government Reform Committee. The CDC documents and discussions with the whistleblower reveal widespread manipulation of scientific data and top-down pressure on CDC scientists to suppress a causal link between the MMR vaccine and later autism diagnosis, particularly in a subset of African-American males who received their immunization “on-time” in accordance with the recommended CDC schedule.

The received documents from the CDC show that in 2003 a 340% increase in autism in African American boys related to the MMR vaccine was discovered and then hidden due to pressure from senior officials. The CDC researchers then recalculated their results by removing a population to get the results that were desired.

William Thompson has worked for the government agency for over a decade

7:06 pm 7:06 pm

Parents Blackmailed By Doctor: Consent To Vaccine Or We Take Your Newborn

July 10th, 2014|blog, Hepatitis B (HBV) Vaccine Ineffectiveness, Hepatitis B (HBV) Vaccine Risk, Vaccine Ineffectiveness, Vaccine Risks|

5/23/2014 Update

Aliea Bidwell is filing suit against the doctor who blackmailed her into the hepatitis B vaccine for her son.

The family has set up a Web site to spread the word about her family’s ordeal. They are accepting donations to offset legal costs.

Original Report

Aliea Bidwell and Ben Gray were as excited as any other couple when their baby boy was born. Vaccine blackmail was the furthest thought from their minds. But because a pediatrician on call didn’t like their decision to refuse a vaccine, she threatened to kidnap their newborn (through legal channels, of course), if they did not consent on day one to something they neither wanted nor felt was worth the risks. It was vaccine blackmail. They were given no choice.

Aliea and Ben are certainly not the first parents to refuse vaccines, and the hospital staff showed no indication of any problem with honoring their request, until Dr. Terry M. Bierd, MD, staff pediatrician at St. Vincent’s Hospital in Birmingham, came in. It was the hepatitis B vaccine that was the problem. She told baby Aaron’s family that if they did not allow her to give the hepatitis B vaccine, she would call security and DHR (Alabama’s Child Protective Services). The baby would be given the vaccine anyway, at 12 hours old, and then be taken into state custody.

Because it was a Friday evening, Dr. Bierd told Aliea and Ben that they would have to figure out how to get their baby back

2:40 pm 2:40 pm

Researcher Charged in Major HIV Vaccine Fraud Case

June 27th, 2014|AIDS/HIV Vaccine Ineffectiveness, AIDS/HIV Vaccine Risk, blog, Vaccine Ineffectiveness, Vaccine Risks|

Responding to a major case of research misconduct, federal prosecutors have taken the rare step of filing charges against a scientist after he admitted falsifying data that led to millions in grants and hopes of a breakthrough in AIDS vaccine research.

Investigators say former Iowa State University laboratory manager Dong-Pyou Han has confessed to spiking samples of rabbit blood with human antibodies to make an experimental HIV vaccine appear to have great promise. After years of work and millions in National Institutes of Health grants, another laboratory uncovered irregularities that suggested the results — once hailed as groundbreaking — were bogus.

Han was indicted last week on four counts of making false statements, each of which carries up to five years in prison. He was set to be arraigned Tuesday in Des Moines, but he didn’t show up due to an apparent paperwork mix-up. A prosecutor said Han will be given another chance to appear next week.

Han, 57, didn’t return a message left at his home in Cleveland, where he’s been living since resigning from the university last fall. A native of South Korea, he surrendered his passport following his arrest and initial court appearance in Ohio last week.

Experts said the fraud was extraordinary and that charges are rarely brought in such cases. The National Institutes of Health said it’s reviewing what impact the case has had on the research it funds.

“It’s an important case because it is extremely rare for scientists found to have committed fraud to be held accountable by

1:17 pm 1:17 pm

As Merck preps newest HPV vaccine, questions remain about Gardisil’s safety

May 16th, 2014|Human Papillomavirus, Human Papillomavirus (HPV) Vaccine Ineffectiveness, Human Papillomavirus (HPV) Vaccine Risk|

The pediatrician was persistent.

This was a life-saving vaccine, afterall. Why wouldn’t Theresa Tomoser want to vaccinate her 14-year-old daughter?

In December 2009, the Tampa-area mother felt like she couldn’t put it off any longer and took her daughter, Danielle, to get the shot.

The shot was the first in a series of what should have been three doses of the quadrivalent human papillomavirus vaccine, better known as Gardisil.

Merck Pharmaceuticals was first approved by the Food and Drug Administration in 2006 to use Gardisil in females ages 9 to 26.

Merck’s research had shown the vaccine to prevent HPV types 16 and 18, which are the cause of about 70 percent of all cervical cancers, as well as types 6 and 11, which are responsible for genital warts.

Read Full Article: http://m.clickorlando.com/news/as-merck-preps-newest-hpv-vaccine-questions-remain-about-gardisils-safety/25979168

By: By Lauren Sweeney, Special Projects Producer